Elekta (OTCMKTS:EKTAY) Shares Gap Down – Here’s What Happened

Elekta AB (OTCMKTS:EKTAY)’s share price gapped down before the market opened on Thursday . The stock had previously closed at $5.39, but opened at $5.1150. Elekta shares last traded at $5.1150, with a volume of 753 shares traded.

Analyst Upgrades and Downgrades

Separately, Zacks Research upgraded shares of Elekta from a “strong sell” rating to a “hold” rating in a research note on Tuesday, July 28th. One research analyst has rated the stock with a Hold rating, According to MarketBeat, Elekta presently has an average rating of “Hold”.

Elekta Price Performance

The stock has a market cap of $1.89 billion, a P/E ratio of -42.62 and a beta of 1.05. The business has a 50 day simple moving average of $5.27 and a 200-day simple moving average of $5.66. The company has a debt-to-equity ratio of 0.47, a quick ratio of 0.68 and a current ratio of 0.87.

Elekta (OTCMKTS:EKTAY) last released its earnings results on Thursday, August 27th. The company reported $0.07 EPS for the quarter. The company had revenue of $372.30 million for the quarter. Elekta had a positive return on equity of 13.31% and a negative net margin of 2.38%. On average, sell-side analysts forecast that Elekta AB will post 0.43 EPS for the current year.

About Elekta

Elekta is a global medical technology company specializing in the development, manufacture and support of precision radiation therapy and radiosurgery equipment. Its products and services aim to improve patient outcomes in oncology and neurosurgery by combining advanced hardware, software and clinical workflow solutions. Elekta’s offerings are designed to address a broad range of cancer types and brain disorders through targeted, image-guided treatments.

The company’s core product portfolio includes linear accelerators for external beam radiation therapy, stereotactic radiosurgery systems such as the renowned Gamma Knife platform, and brachytherapy solutions for internal radiation treatment.